Barclays’s Stevanato STVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Sell
7,392
-387
-5% -$6.54K ﹤0.01% 3917
2026
Q1
$107K Buy
+7,779
New +$129K ﹤0.01% 3994
2024
Q3
Sell
-56,100
Closed -$1.03M 5469
2024
Q2
$1.03M Sell
56,100
-145,150
-72% -$3.38M ﹤0.01% 2584
2024
Q1
$6.46M Buy
201,250
+147,150
+272% +$4.48M ﹤0.01% 1680
2023
Q4
$1.48M Buy
54,100
+53,400
+7,629% +$1.54M ﹤0.01% 3153
2023
Q3
$20.8K Sell
700
-29,100
-98% -$911K ﹤0.01% 4171
2023
Q2
$965K Hold
29,800
﹤0.01% 2331
2023
Q1
$772K Hold
29,800
﹤0.01% 2930
2022
Q4
$536K Sell
29,800
-12,800
-30% -$212K ﹤0.01% 3273
2022
Q3
$722K Buy
+42,600
New +$716K ﹤0.01% 2458

Other funds holding STVN

Barclays's STVN Position: Q2 2026 in Review

Barclays reduced its Stevanato (STVN) stake by 5% in Q2 2026, selling an estimated $6.54K and leaving 7,392 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #3917.

Barclays first reported a position in STVN in Q3 2022 and has held it in 10 quarters since. The position peaked at $6.46M in Q1 2024. 125 funds tracked by Wall St. Rank hold STVN as of Q2 2026.

  • Barclays held 7,392 shares of Stevanato worth $134K as of Q2 2026.
  • Barclays sold 387 Stevanato shares in Q2 2026, an estimated $6.54K.
  • Stevanato made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3917 holding.
  • Barclays first reported a position in Stevanato in Q3 2022 and has held it in 10 quarters since.
  • Barclays's Stevanato position peaked at $6.46M in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Stevanato as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.